Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Arianna Bertolani"'
Autor:
Viviana Giannuzzi, Arianna Bertolani, Silvia Torretta, Giorgio Reggiardo, Eleonora Toich, Donato Bonifazi, Adriana Ceci
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionThe European Medicines Agency (EMA) offers scientific advice to support the qualification procedure of novel methodologies, such as preclinical and in vitro models, biomarkers, and pharmacometric methods, thereby endorsing their acceptabi
Externí odkaz:
https://doaj.org/article/8a34c496f14547ed9df7bdb0329ccc41
Publikováno v:
Global & Regional Health Technology Assessment, Vol 9, Iss 1 (2022)
Background. Several health care services are required to get eligibility to PCSK9-inhibitors medicines and the follow-up of patients being treated. The ultimate goal is making prescriptions appropriate and monitoring the effects of these drugs. Some
Externí odkaz:
https://doaj.org/article/138fe890f28a4768a3bd0b670edde512
Publikováno v:
Global & Regional Health Technology Assessment, Vol 8 (2021)
Introduction: Dedicated Funds for Innovative Medicines were introduced in 2017 for cancer and non-cancer drugs in Italy. After three years, their impact on patient access to the relevant treatments and critical issues about their management has been
Externí odkaz:
https://doaj.org/article/9f5f16448fed44c48b593b2a966fc014
Publikováno v:
Global & Regional Health Technology Assessment, Vol 5, Iss 1 (2018)
Externí odkaz:
https://doaj.org/article/12961755de0749f0a847ff3eb1d19869
Publikováno v:
Global & Regional Health Technology Assessment, Vol 2018 (2018)
Introduction: The codes used to report hospital admissions due to influenza viruses are likely to underestimate the real incidence of influenza-related cases. Methods: In order to estimate this burden we ran a negative binomial model, in which the nu
Externí odkaz:
https://doaj.org/article/1adc1d807df54c49aad058589fca6e4e
Publikováno v:
Global & Regional Health Technology Assessment, Vol 5, Iss 1 (2018)
Externí odkaz:
https://doaj.org/article/7a2c90dd03764e198a6b858e367f2302
Publikováno v:
Global & Regional Health Technology Assessment, Vol 2018 (2018)
Introduction: This article aims at investigating the 5-year budget impact of rituximab biosimilars in Italy. Methods: A budget impact analysis model was developed in accordance with the International Society For Pharmacoeconomics and Outcomes Researc
Externí odkaz:
https://doaj.org/article/cef58f206f594d64a7e23224e8aeb54f
Publikováno v:
Global & Regional Health Technology Assessment, Vol 5, Iss 1 (2018)
Externí odkaz:
https://doaj.org/article/d60a67eda3184eb2aa89c59c1d562fda
Publikováno v:
Global & Regional Health Technology Assessment, Vol 2018 (2018)
Introduction: This paper aims at investigating the role of Patients’ Associations in drugs assessment and appraisal in Italy. Methods: Information were gathered through a mostly structured (forced ranking) questionnaire. The questionnaire, once val
Externí odkaz:
https://doaj.org/article/e20093a4b0004793b0249d3301f42a32
Publikováno v:
Clinical Drug Investigation
Background and Objectives Second-generation antipsychotics (SGAs) for schizophrenia show different risk profiles, whose evidence has been evaluated through comparative reviews on randomized controlled trials (RCTs) and observational studies. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::093fda49c0eab910e07506d7b7adc8b2
https://doi.org/10.1007/s40261-021-01000-1
https://doi.org/10.1007/s40261-021-01000-1